| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.3 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |